We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Correspondence |

Neuromyelitis Optica and the Optic Neuritis Treatment Trial

Marc Gotkine, MBBS
Arch Neurol. 2008;65(11):1545-1546. doi:10.1001/archneur.65.11.1545-c.
Text Size: A A A
Published online


The long-term results of the Optic Neuritis Treatment Trial (ONTT)1 will certainly allow clinicians to provide clearer information to people presenting with an initial episode of optic neuritis and may also facilitate better design of treatment trials.

Although it is unlikely that many patients in the sample had their serum tested for neuromyelitis optica (NMO) IgG, it would be interesting to know how many went on to develop a longitudinally extensive spinal cord lesion as it is possible that some of them now fulfill the revised diagnostic criteria for NMO as proposed by Wingerchuk et al.2 Furthermore, the data may suggest ways of predicting the future development of NMO, especially as characteristic brain magnetic resonance imaging features have been described.3,4

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





November 10, 2008
Vivien H. Lee, MD; Eelco F. M. Wijdicks, MD; Edward M. Manno, MD; Alejandro A. Rabinstein, MD
Arch Neurol. 2008;65(11):1545. doi:10.1001/archneur.65.11.1545-b.
November 10, 2008
Craig H. Smith, MD
Arch Neurol. 2008;65(11):1546. doi:10.1001/archneur.65.11.1546-a.
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Articles Related By Topic
Related Collections
PubMed Articles